Doximity (NYSE:DOCS) Upgraded to “Strong-Buy” at Zacks Research

Zacks Research upgraded shares of Doximity (NYSE:DOCS) from a hold rating to a strong-buy rating in a report issued on Monday morning,Zacks.com reports.

A number of other analysts have also weighed in on DOCS. Wall Street Zen lowered Doximity from a “buy” rating to a “hold” rating in a report on Saturday, January 10th. Wells Fargo & Company raised Doximity from an “equal weight” rating to an “overweight” rating and set a $55.00 price target for the company in a research report on Tuesday, January 20th. Barclays upgraded Doximity to a “strong-buy” rating in a research note on Monday, December 8th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Doximity in a research note on Wednesday, December 24th. Finally, Royal Bank Of Canada raised shares of Doximity to a “moderate buy” rating in a research report on Thursday, January 8th. Three analysts have rated the stock with a Strong Buy rating, two have issued a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy” and an average target price of $55.00.

Doximity Stock Down 0.5%

NYSE:DOCS traded down $0.20 during midday trading on Monday, hitting $38.76. The stock had a trading volume of 448,504 shares, compared to its average volume of 2,529,980. The stock has a market cap of $7.30 billion, a P/E ratio of 30.76, a price-to-earnings-growth ratio of 1.87 and a beta of 1.39. Doximity has a one year low of $38.72 and a one year high of $85.21.

About Doximity

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.